MAHSC Honorary Clinical Professor
The University of Manchester
Consultant Vascular and Endovascular Surgeon
Manchester University NHS Foundation Trust
Manchester, United Kingdom
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
DEBATE: Patient Survival After EVAR Was NOT Improved By Compliance With Surveillance Protocols: The EVAR Surveillance Paradox: From A Systematic Meta-Analysis: What Is The Explanation
1:18 PM - 1:23 PM
Presenter
SESSION 5: NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
Why EVAR Should Be Preferred Over Open Repair In Young Patients With Suitable Anatomy: From A Meta-Analysis Of >50,000 Patients
2:18 PM - 2:23 PM
Presenter
SESSION 43: MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAS ARE NOT TIME BOMBS WAITING TO EXPLODE
EVAR Patients On Anticoagulation Have Increased Mortality, Endoleaks, Sac Expansion And Reinterventions: From A Meta-Analysis Of >35,000 Patients
1:18 PM - 1:23 PM
Presenter
SESSION 108: AORTIC TOPICS TOO IMPORTANT TO MISS AND SPINE EXPOSURE
Outcomes Of EVAR In Over 18,000 High-Risk Patients Ineligible For Open Repair: When Is EVAR Justified Over No Intervention In Such Patients: Why Is EVAR 2 No Longer Relevant
10:00 AM - 10:05 AM